BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28206963)

  • 1. Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer.
    Wang X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Zhang A; Shen D; Zheng C; Qi J; Zhao D; Shi J; Jin L; Rao J; Zhang W
    Oncotarget; 2017 Apr; 8(15):24892-24901. PubMed ID: 28206963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
    Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
    Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
    Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
    J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer.
    Dai C; Zhang X; Ma Y; Chen Z; Chen S; Zhang Y; Li M
    Biomarkers; 2021 Nov; 26(7):598-605. PubMed ID: 34266319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
    Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
    Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer.
    Vocka M; Langer D; Fryba V; Petrtyl J; Hanus T; Kalousova M; Zima T; Petruzelka L
    Cancer Biomark; 2018; 21(4):869-874. PubMed ID: 29400662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.
    Ostendorff HP; Awad A; Braunschweiger KI; Liu Z; Wan Z; Rothschild KJ; Lim MJ
    J Immunol Methods; 2013 Dec; 400-401():58-69. PubMed ID: 24161315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
    Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
    Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients.
    Pakdel A; Malekzadeh M; Naghibalhossaini F
    Cancer Biomark; 2016; 16(2):245-52. PubMed ID: 26756614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.
    Han SX; Wang J; Wang LJ; Jin GH; Ying X; He CC; Guo XJ; Zhang JY; Zhang Y; Zhu Q
    Tumour Biol; 2014 Jun; 35(6):6149-57. PubMed ID: 24652591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble intercellular adhesion molecule-1 is a prognostic marker in colorectal carcinoma.
    Schellerer VS; Langheinrich MC; Zver V; Grützmann R; Stürzl M; Gefeller O; Naschberger E; Merkel S
    Int J Colorectal Dis; 2019 Feb; 34(2):309-317. PubMed ID: 30470940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serpin B5 is a CEA-interacting biomarker for colorectal cancer.
    Baek JY; Yeo HY; Chang HJ; Kim KH; Kim SY; Park JW; Park SC; Choi HS; Kim DY; Oh JH
    Int J Cancer; 2014 Apr; 134(7):1595-604. PubMed ID: 24114705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
    Huang SC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Lin CC; Jiang JK; Chang SC
    Ann Surg Oncol; 2015 Jul; 22(7):2262-8. PubMed ID: 25586242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.